Russell Investments Group, Ltd.

Position in SVRA — Savara Inc

CIK 1692234 Seattle, WA

Position in SVRA

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$556,308

+$497,357 QoQ

Shares Held

90,310

+736.4% QoQ

Ownership

0.044%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#78

of 181 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 45% Shared 0% None 55%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. SVRA ranks #144 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$556,308	90,310	+736.4%	Shares	Defined	2026-08-06
2026-03-31	$58,951	10,797	-4.0%	Shares	Defined	2026-05-08
2025-12-31	$67,843	11,251	+7.4%	Shares	Defined	2026-02-17
2025-09-30	$37,413	10,480	+930.5%	Shares	Defined	2025-11-13
2025-06-30	$2,318	1,017	-0.9%	Shares	Defined	2025-08-13
2024-12-31	$3,149	1,026	-46.8%	Shares	Defined	2025-02-13
2024-06-30	$7,765	1,927	+1466.7%	Shares	Defined	2024-08-08
2024-03-31	$612	123	-99.8%	Shares	Defined	2024-05-08
2021-09-30	$85,216	61,752	-14.8%	Shares	Sole	2021-11-08
2021-06-30	$123,146	72,439	-70.9%	Shares	Sole	2021-08-04
2021-03-31	$517,052	248,583	+109.0%	Shares	Sole	2021-05-10
2020-09-30	$129,644	118,940	+2278.8%	Shares	Defined	2020-11-09
2020-06-30	$12,450	5,000	—	Shares	Defined	2020-08-05
No filing history on record for this holder in this stock.